Riskpilot← Back to searchSign inGet full accessBIOSUPPORT AS
ASActiveOrg 918463623Operagata 16 A301, 0194 OsloEngineering activities and related technical consultancy · NACE 7112Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
-116% vs 2023
Equity ratio
97.7%
Financial strength
Net profit 2024
NOK -53K
-126% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -44K | -116% |
| Net profit | NOK -53K | -126% |
| Total assets | NOK 229K | -36% |
| Equity | NOK 223K | -19% |
| Employees | 0 | — |
Legal name
BIOSUPPORT AS
Org number
918463623
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
30. januar 2017
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Salg av konsulenttjenester innen bioteknologi, hovedsakelig innen legemiddel- og diagnostikk-bransjen. Utleie av arbeidskraft og alt hva hermed er i forbindelse, samt å investere i fast eiendom, aksjer, og andre verdipapirer, samt virksomhet som står i forbindelse med dette.
Address
Operagata 16 A301, 0194 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 690 | 1 662 | 1 632 | 535 | 0 |
| Staff expenses | −783 | −820 | −884 | −222 | −0 |
| EBITDA | 822 | 760 | 628 | 265 | −44 |
| Depreciation & amort. | −0 | −0 | −0 | −6 | −11 |
| EBIT | 822 | 760 | 628 | 259 | −55 |
| Net financials | −0 | 0 | 0 | 0 | 0 |
| Profit before tax | 822 | 760 | 628 | 259 | −54 |
| Tax | 181 | 167 | 138 | 57 | −1 |
| Net profit | 641 | 593 | 490 | 202 | −53 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 044 | 979 | 876 | 356 | 229 |
| Equity | 31 | 34 | 75 | 277 | 223 |
| Long-term debt | 0 | 0 | 0 | 1 | 0 |
| Short-term debt | 1 012 | 944 | 802 | 78 | 5 |
| Total debt | 1 012 | 944 | 802 | 79 | 5 |
EBITDA margin
-4374900.0%
This company
15.8%
Market median
-27689341% vs market
20202024
Equity ratio
97.7%
This company
38.2%
Market median
+156% vs market
20202024
Return on equity
-23.9%
This company
18.4%
Market median
-230% vs market
20202024
Net profit margin
-5337900.0%
This company
8.1%
Market median
-65900100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AT Deputy Member | Deputy Member | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOSUPPORT AS 
Poppel Vinbar AsBoard members of BIOSUPPORT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Thoresen Fjelstad | Deputy Member | 0 companies |
| Jørgen Fjelstad | Board of Directors | 0 companies |
| Grete Thoresen Fjelstad | Chairman | 0 companies |